Blog Voices from the Frontlines
Dose reduction may improve pain, function, and quality of life for patients prescribed long-term opioid therapy for chronic pain. Results of a systematic evidence review are published in Annals of Internal Medicine.
Approximately 10 million U.S. adults are prescribed long-term opioid therapy for chronic pain. This dramatic increase in opioid prescribing has been accompanied by increases in opioid overdose. Expert guidelines recommend reducing or discontinuing long-term opioid therapy when risks outweigh the benefits, but evidence on the effects of dose reduction on patient outcomes had not been systematically reviewed.
In the July 2017 Issue:
- Mexico President Approves Safe Access
- Greece Announces Medical Access
- Attorney General Asks Congress to End Patient Protections
- New Revision to Cannabis Law for California
- ASA Urges Administration to Fight Opiate Crisis with Cannabis
- PFC Launches Training with Univ. of Maryland
- PFC Webinars Offer Online Help for Businesses
- ASA Activist Profile: Frank Buress, Wisconsin
- National Action Alert: Urge Congress to Renew Patient Protections
The ONLY thing protecting state medical cannabis programs from Attorney General Jeff Session’s Department of Justice (DOJ) raids and arrests is an amendment to the Commerce, Justice, Science and Related Agencies (CJS) budget that prohibits the DOJ from spending federal funds to prosecute anyone participating in a medical cannabis program as long as they are abiding by state laws.
Contact your Representative TODAY and ask them to ensure that protections for state medical cannabis programs are in the budget for fiscal year 2018.
On June 26, 2017, in Salt Lake City, patients, advocates, and their families introduced a ballot initiative application that would allow for a comprehensive medical cannabis program in Utah. The initiative grew from patient advocates and their families who are frustrated by the inability of the Utah legislators to pass comprehensive medical cannabis bills. This initiative would allow Utah voters decide if they wanted to legalize medical use of the whole cannabis plant in their state.
In the June 2017 Issue:
- CARERS Act Revived in Congress with Added Co-Sponsors
- Safe Access Tennessee Launches Grassroots Patient Groups
- PFC at Forefront of International Standards Development
- California Lobby Day Draws 200 Advocates
- Maryland Program Delays Spur Patient Protest
- ASA Activist Profile: Nichole Miller, Caregiver, Virginia
- ACTION ALERT: Urge your Senators to support CARERS!
On June 16, President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis held its first meeting to begin formulating recommendations on how to combat the opioid epidemic. The meeting provided compelling stories and thoughtful suggestions on how to resolve the opioid crisis. However, the suggestions that came out of this meeting were narrow; an increase in the availability and use of Naxolone or Narcan, which is a pharmaceutical that blocks the effects of opioids, further doctor education on the prescribing of opioids, and broad adoption of CDC guidelines and basing policy on evidence based research.
Medical Cannabis Advocates Call on Trump Administration to Use all Tools Available to Fight Opiate Crisis - Americans for Safe Access
Americans for Safe Access Submits Comments at Trump’s first official meeting to address drug addiction, opioid abuse
WASHINGTON, DC — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Christie is joined on the Commission by Gov Charlie Baker (MA), Gov. Roy Cooper (NC), Rep. Patrick Kennedy and Professor Bertha Madras, Ph.D.
Reintroduced CARERS Act Would Protect States' Rights, Medical Marijuana Patients - Americans for Safe Access
By Thomas Mitchell for Westword
Days after a letter from Attorney General Jeff Sessions surfaced, asking congressional leaders to revoke federal protections for medical marijuana, senators have introduced a bill that would protect medical marijuana patients in states where it's legal while also removing cannabidiol (CBD) from the Controlled Substances Act and expanding research on marijuana.
Great news: the Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 was introduced in the U.S. Senate this afternoon!
The bill is being introduced by Senators Kirsten Gillibrand (New York), Cory Booker (New Jersey), Al Franken (Minnesota), and Rand Paul (Kentucky). This year, we have two new Republican senators who are joining the fight to protect access to our medicine - Senator Lisa Murkowski (Alaska) and Senator Mike Lee (Utah).
The CARERS Act is vital legislation that will safeguard patients in states with medical cannabis programs, and expand research opportunities so that we learn even more about our medicine. For the past three years, we have been the driving force behind this legislation to help push it forward, working hard each and every day to make sure that it would be introduced and included additional co-sponsors this year. We worked closely with Senators and their staff to make sure that important protections were included in the bill’s language.
The hundreds of patient advocates who visited their Members of Congress at this year’s National Unity Conference sent Congress a strong message:
We need the CARERS Act!
And now, with the bill’s introduction this afternoon at a press conference coordinated by ASA staff, CARERS is becoming a reality. There is no way we could have done all of this without the support of members like you.
So how can you help pass CARERS?
Here's 3 Simple Things You Can Do Right Now
Donate to ASA.
Share our messages on social media.